Endoscopic Procedure May Prevent Weight Regain After GLP-1 Discontinuation

Simple procedure found to prevent weight rebound after discontinuing GLP-1 drugs

Minimally invasive endoscopic procedure may offer ‘lasting weight loss maintenance’, scientists say

Simple 'gut reset' procedure may prevent weight rebound following GLP-1 discontinuation

An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid regaining the pounds they shed, according to a study presented at Digestive Disease Week (DDW) 2026.

Endoscopic procedure may prevent weight regain after GLP-1 discontinuation

An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid regaining the pounds they shed, according to a study to be presented at Digestive Disease Week (DDW) 2026.

Simple “gut reset” may stop weight gain after Ozempic or Wegovy

A new minimally invasive procedure may help people keep weight off after stopping popular drugs like Ozempic and semaglutide—something most patients struggle with. In a clinical trial, those who underwent a technique called duodenal mucosal resurfacing regained far less weight compared to others after discontinuing the medication. The procedure works by renewing the lining of the upper small intestine, potentially “resetting” metabolism and pres…

Intestinal procedure reduces weight regain after discontinuing Ozempic and Wegovy

Duodenal Mucosal Resurfacing Slows Post-Tirzepatide Weight Regain

Early results from a pilot study show the minimally invasive endoscopic intervention reduces the weight gain that occurs following discontinuation of anti-obesity medications.